Making the discoveries that defeat cancer

  • Home »
  • Research »
  • Repository

  • Administrators Login

  • Repository Homepage
  • About the Repository
  • Browse the Repository
  • Search the Repository
  • Contribute an Article
  • Missing Publications
  • Repository Help

Combining fulvestrant (Faslodex (TM)) with continued oestrogen suppression in endocrine-sensitive advanced breast cancer: the SoFEA trial

Tools
- Tools
+ Tools

Dodwell, D., Coombes, G., Bliss, J. M., Kilburn, L. S., Johnston, S., SoFEA Trial Management Grp, [Group Author] (2008) Combining fulvestrant (Faslodex (TM)) with continued oestrogen suppression in endocrine-sensitive advanced breast cancer: the SoFEA trial. CLINICAL ONCOLOGY, 20 (5). pp. 321-324. ISSN 0936-6555

Full text not available from this repository.

Item Type: Editorial
Authors (ICR Faculty only): Johnston, Stephen and Bliss, Judith
All Authors: Dodwell, D., Coombes, G., Bliss, J. M., Kilburn, L. S., Johnston, S., SoFEA Trial Management Grp, [Group Author]
Uncontrolled Keywords: 2 MULTICENTER TRIALS; FIRST-LINE THERAPY; POSTMENOPAUSAL WOMEN; TAMOXIFEN; ANASTROZOLE; DEPRIVATION; EXEMESTANE; CARCINOMA; SUPERIOR; CELLS
Research teams: Clinical Units > Breast Unit
ICR divisions > Clinical Studies > Clinical Trials & Statistics Unit
Depositing User: Users 10 not found.
Date Deposited: 01 Jul 2008 08:52
Last Modified: 10 Feb 2010 11:49
URI: http://publications.icr.ac.uk/id/eprint/6483

Actions (login required)

View Item View Item
The Royal Marsden - NHS foundation trust